Nuclear receptor drug discovery
- 26 July 2008
- journal article
- review article
- Published by Elsevier in Current Opinion in Chemical Biology
- Vol. 12 (4), 418-426
- https://doi.org/10.1016/j.cbpa.2008.07.001
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Drugs and their molecular targets: an updated overviewFundamental & Clinical Pharmacology, 2008
- Selective Estrogen-Receptor Modulators and Antihormonal Resistance in Breast CancerJournal of Clinical Oncology, 2007
- Nuclear receptors: Decoding metabolic diseaseFEBS Letters, 2007
- Panning for SNuRMs: using cofactor profiling for the rational discovery of selective nuclear receptor modulatorsDrug Discovery Today, 2007
- Design of selective nuclear receptor modulators: RAR and RXR as a case studyNature Reviews Drug Discovery, 2007
- Molecular basis of selective PPARγ modulation for the treatment of Type 2 diabetesBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2007
- Separating Transrepression and Transactivation: A Distressing Divorce for the Glucocorticoid Receptor?Molecular Pharmacology, 2007
- Selective glucocorticoid receptor agonists (SEGRAs): Novel ligands with an improved therapeutic indexMolecular and Cellular Endocrinology, 2007
- A Novel Antiinflammatory Maintains Glucocorticoid Efficacy with Reduced Side EffectsMolecular Endocrinology, 2003
- Therapeutic Benefit of a Dissociated Glucocorticoid and the Relevance of In Vitro Separation of Transrepression from Transactivation ActivityThe Journal of Immunology, 2001